International multi-stakeholder consensus statement on clinical trial integrity

International multi-stakeholder consensus statement on clinical trial integrity

Abstract Objective To prepare a set of statements for randomised clinical trials (RCT) integrity through an international multi-stakeholder consensus. Methods The consensus was developed via multi-country multidisciplinary stakeholder group composition and engagement; evidence synthesis of 55 system...

Full description

Bibliographic Details
Main Authors:	Khalid Saeed Khan, for the Cairo Consensus Group on Research Integrity
Format:	Article
Language:	English
Published:	SpringerOpen 2024-04-01
Series:	Middle East Fertility Society Journal
Subjects:	randomised controlled trials research integrity
Online Access:	https://doi.org/10.1186/s43043-024-00171-z

Similar Items

Checklist to assess Trustworthiness in RAndomised Controlled Trials (TRACT checklist): concept proposal and pilot
by: Ben W. Mol, et al.
Published: (2023-06-01)

Letter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK – experience from the ActWELL trial”
by: Hanne Bruhn, et al.
Published: (2021-06-01)

Heterogeneity in pragmatic randomised trials: sources and management
by: Bruno Giraudeau, et al.
Published: (2022-10-01)

Trials Methodology Research: what is it and why should India invest in it?
by: Sangeetha Paramasivan, et al.
Published: (2024-03-01)

Improving recruitment to a study of telehealth management for COPD: a cluster randomised controlled ‘study within a trial’ (SWAT) of a multimedia information resource
by: Kate Jolly, et al.
Published: (2019-07-01)

Surrogate endpoints in trials: a call for better reporting
by: Oriana Ciani, et al.
Published: (2022-12-01)

Characteristics and practices of school-based cluster randomised controlled trials for improving health outcomes in pupils in the United Kingdom: a methodological systematic review
by: Kitty Parker, et al.
Published: (2021-07-01)

The randomized clinical trial trustworthiness crisis
by: Furqan A. Butt, et al.
Published: (2024-01-01)

Registration of noncommercial randomised clinical trials: the feasibility of using trial registries to monitor the number of trials
by: Raftery James, et al.
Published: (2012-08-01)

Insufficient recruitment and premature discontinuation of clinical trials in Switzerland: qualitative study with trialists and other stakeholders
by: Matthias Briel, et al.
Published: (2017-11-01)

Insufficient recruitment and premature discontinuation of clinical trials in Switzerland: qualitative study with trialists and other stakeholders
by: Matthias Briel, et al.
Published: (2017-08-01)

A longitudinal assessment of trial protocols approved by research ethics committees: The Adherance to SPIrit REcommendations in the UK (ASPIRE-UK) study
by: Benjamin Speich, et al.
Published: (2022-07-01)

Designing clinical trials
by: Smita Narayan
Published: (2021-01-01)

Undertaking multi-centre randomised controlled trials in primary care: learnings and recommendations from the PULsE-AI trial researchers
by: Kevin G. Pollock, et al.
Published: (2024-01-01)

Independence estimators for re-randomisation trials in multi-episode settings: a simulation study
by: Brennan C. Kahan, et al.
Published: (2021-10-01)

The APPLE Tree programme: Active Prevention in People at risk of dementia through Lifestyle, bEhaviour change and Technology to build REsiliEnce—randomised controlled trial
by: M. Poppe, et al.
Published: (2022-07-01)

Design considerations for clinical trials in aphasia
by: Rebecca Palmer
Published: (2020-01-01)

Uses of equipoise in discussions of the ethics of randomized controlled trials of COVID-19 therapies
by: Hayden P. Nix, et al.
Published: (2021-10-01)

Exploring trial publication and research waste in COVID-19 randomised trials of hydroxychloroquine, corticosteroids, and vitamin D: a meta-epidemiological cohort study
by: Lisa Fincham, et al.
Published: (2024-01-01)

Contamination in complex healthcare trials: the falls in care homes (FinCH) study experience
by: K. Robinson, et al.
Published: (2020-02-01)

Rivers of Evidence
by: Clive Adams
Published: (2013-11-01)

Extended data - Appendices - A randomised controlled trial of tamoxifen for cryptococcal meningitis
by: Day, J
Published: (2019)

Community perspectives on randomisation and fairness in a cluster randomised controlled trial in Zambia
by: Maureen Mupeta Kombe, et al.
Published: (2019-12-01)

Improving the reproducibility and integrity of research: what can different stakeholders contribute?
by: Malcolm Macleod, et al.
Published: (2022-04-01)

‘We all want to succeed, but we’ve also got to be realistic about what is happening’: an ethnographic study of relationships in trial oversight and their impact
by: Anne Daykin, et al.
Published: (2017-12-01)

Multi-centric clinic trials in evidence-based research – A narrative review on the Indian scenario
by: Deepa J Patil, et al.
Published: (2023-01-01)

Reporting guidelines for clinical trials of artificial intelligence interventions: the SPIRIT-AI and CONSORT-AI guidelines
by: Hussein Ibrahim, et al.
Published: (2021-01-01)

A blueprint for a multi-disease, multi-domain Bayesian adaptive platform trial incorporating adult and paediatric subgroups: the Staphylococcus aureus Network Adaptive Platform trial
by: Robert K. Mahar, et al.
Published: (2023-12-01)

Letter on Predicting the number of sites needed to deliver a multicentre clinical trial within a limited time frame in the UK
by: Rosemary Greenwood, et al.
Published: (2020-10-01)

Data Resource Profile: the Virtual International Care Homes Trials Archive (VICHTA)
by: Lisa Irvine, et al.
Published: (2024-01-01)

The high-volume haemodiafiltration vs high-flux haemodialysis registry trial (H4RT): a multi-centre, unblinded, randomised, parallel-group, superiority study to compare the effectiveness and cost-effectiveness of high-volume haemodiafiltration and high-flux haemodialysis in people with kidney failure on maintenance dialysis using linkage to routine healthcare databases for outcomes
by: Fergus J. Caskey, et al.
Published: (2022-06-01)

Methodology series module 4: Clinical trials
by: Maninder Singh Setia
Published: (2016-01-01)

Death, bereavement and randomised controlled trials (BRACELET): a methodological study of policy and practice in neonatal and paediatric intensive care trials
by: Claire Snowdon, et al.
Published: (2014-07-01)

Systematic review of the characteristics of school-based feasibility cluster randomised trials of interventions for improving the health of pupils in the UK
by: Kitty Parker, et al.
Published: (2022-07-01)

Ondansetron for irritable bowel syndrome with diarrhoea: randomised controlled trial
by: David Gunn, et al.
Published: (2023-10-01)

How much is the lack of retention evidence costing trial teams in Ireland and the UK?
by: Ellen Murphy, et al.
Published: (2022-05-01)

Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
by: Nisha R. Acharya, et al.
Published: (2020-10-01)

Automated recruitment and randomisation for an efficient randomised controlled trial in primary care
by: Victoria R. Cornelius, et al.
Published: (2018-06-01)

Spotlight on landmark oncology trials: the latest evidence and novel trial designs
by: Helena Earl, et al.
Published: (2017-06-01)

The effect of optimised patient information materials on recruitment in a lung cancer screening trial: an embedded randomised recruitment trial
by: Adwoa Parker, et al.
Published: (2018-09-01)